文献速递呼吸危重症与机械通气

未经证实且昂贵的ECMO与已证实且廉价的俯卧位通气在ARDS中的比较

Unproven and Expensive before Proven and Cheap: Extracorporeal Membrane Oxygenation versus Prone Position in Acute Respiratory Distress Syndrome.
PubMed 文献 · Am J Respir Crit Care Med · 2018-01-01

该文分析了810篇关于ECMO治疗ARDS的报道,其中61篇符合纳入标准,26篇(43%)作者回复确认。基于17篇明确数据(672例VV-ECMO患者),208例(31%)在ECMO前接受过俯卧位通气,464例(69%)未接受。2013年关键RCT发表后,ECMO前使用俯卧位的比例从55%(116/210)降至19%(84/452)(P<0.05),提示文献报告存在系统偏倚。

要点

  • 多数ECMO患者未先接受简单、廉价且已证实有效的俯卧位通气。
  • 2013年后ECMO前俯卧位使用比例显著下降(55%→19%)。
  • ECMO疗效推断因报告偏倚而受限。

核心结论

  • 报道的ECMO患者中绝大多数未先接受俯卧位通气这一简单、廉价且已证实有效的治疗,因此ECMO在ARDS中的疗效推断有限。

研究设计与样本

  • 文献分析:检索810篇ECMO治疗ARDS的报道,61篇符合纳入标准,26篇(43%)作者回复确认,最终17篇提供明确数据,涉及672例VV-ECMO患者。

主要发现

  • 672例VV-ECMO患者中,208例(31%)在ECMO前接受过俯卧位通气,464例(69%)未接受。
  • 2013年关键RCT发表后,ECMO前使用俯卧位的比例在2013年后发表的研究中为84/452(19%),低于2013年前发表研究的116/210(55%)(P<0.05)。

关键数值与推荐

  • 2013年关键RCT(N Engl J Med 2013;368:2159-2168)报告俯卧位通气与生存获益相关。

临床怎么用

  • 在考虑ECMO前,应确保患者已接受俯卧位通气等已证实有效的治疗。

局限性

  • 仅43%的通讯作者回复确认,17篇提供明确数据,可能存在报告偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We identified 810 reports that describe extracorporeal membrane oxygenation (ECMO) in acute respiratory distress syndrome (ARDS), and 61 fulfilled our inclusion criteria. The authors of 26 (43%) reports responded to e-mail requests for confirmation (or clarification). Based on the aggregate (published and e-mailed) information, unambiguous data were available relating to 17 papers. These 17 papers represented 672 patients with ARDS who were cannulated with venovenous ECMO; of these patients, 208 (31%) received a trial of prone positioning before ECMO, and 464 (69%) did not. A key randomized controlled trial was published in 2013 that reported a survival benefit associated with prone positioning (N Engl J Med 2013;368:2159-2168). The proportion of all venovenous ECMO patients in whom prone positioning was used before ECMO was lower in studies published after 2013 (84 of 452 [19%]) than in those published before 2013 (116 of 210 [55%]) (P < 0.05). These data suggest a systematic bias in the reporting of outcomes after ECMO in the literature. The vast majority of reported patients who received ECMO did not first receive therapy that (in contrast to ECMO) is simple, cheap, and of proven benefit; therefore, inferences about the efficacy of ECMO in ARDS are of limited use.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Li X, Scales DC, Kavanagh BP, et al. Unproven and Expensive before Proven and Cheap: Extracorporeal Membrane Oxygenation versus Prone Position in Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2018. PMID: 29313706. doi:10.1164/rccm.201711-2216CP

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。